Augustyns, Koen

When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157

Rojas-Rivera, D., Delvaeye, T., Roelandt, R., Nerinckx, W., Augustyns, K., Vandenabeele, P., & Bertrand, M. J. M. (2017) · Cell Death & Differentiation

Cell death mechanisms and regulationEndoplasmic Reticulum Stress and Disease

Cited by 206

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death

Van Coillie, S., Van San, E., Goetschalckx, I., Wiernicki, B., Mukhopadhyay, B., Tonnus, W., Choi, S. M., Roelandt, R., Dumitrascu, C., Lamberts, L., et al. (2022) · Nature Communications

Ferroptosis and cancer prognosisIron Metabolism and Disorders

Cited by 186

Targeting ferroptosis protects against multiorgan dysfunction and death.

VandenBerghe, T., Coillie, S. V., Goetschalckx, I., Wiernicki, B., Mukhopadhyay, B., Tonnus, W., San, E. V., Choi, S. M., Roelandt, R., Dumitrascu, C., et al. (2021) · Nature Communications

Ferroptosis and cancer prognosisIron Metabolism and Disorders

Cited by 186

Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression

Van San, E., Debruyne, A. C., Veeckmans, G., Tyurina, Y. Y., Tyurin, V. A., Zheng, H., Choi, S. M., Augustyns, K., van Loo, G., Michalke, B., et al. (2023) · Cell Death & Differentiation

Multiple Sclerosis Research StudiesFerroptosis and cancer prognosis

Cited by 103

Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome

Ceuleers, H., Hanning, N., Heirbaut, J., Van Remoortel, S., Joossens, J., Van Der Veken, P., Francque, S. M., De bruyn, M., Lambeir, A., De Man, J. G., et al. (2018) · British Journal of Pharmacology

Gastrointestinal motility and disordersPain Mechanisms and Treatments

Cited by 49